Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can cause significant social and emotional issues, especially for women and young men.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Topical sensitizers have mixed success in treating alopecia areata.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Hair restoration surgery can improve happiness, confidence, and social aspects of life, especially in younger patients with early hair loss.

Vitamin A helps skin stem cells decide their function, aiding in hair growth and wound repair.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

New understanding and treatments for hair loss are improving, but more research is needed.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Non-coding RNAs could help detect and treat radiation damage.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Minoxidil can reduce functions related to androgen receptors.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.